BioRestorative Therapies BRTX
NASDAQ BRTX
$0.22 -0.01 (-2.40%)
At close: Aug 21, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Amortizatization of Intangibles (2010 - 2021)

BioRestorative Therapies' (BRTX) quarterly Amortizatization of Intangibles came in at $65041.0 in Q4 2021, up 104.24% YoY from $31844.9 in Q4 2020, and down 80.05% on a QoQ basis from $325964.0 in Q3 2021.

BioRestorative Therapies (BRTX) Amortizatization of Intangibles (2010 - 2021) Analysis & Trends

BioRestorative Therapies (BRTX) has 12 years of Amortizatization of Intangibles data on file, last reported at $65041.0 in Q4 2021.

  • Quarterly Amortizatization of Intangibles rose 104.24% year-over-year to $65041.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $1.1 million (down 11.31% YoY) and the FY2021 annual result came in at $1.1 million, down 11.31% from the prior year.
  • Amortizatization of Intangibles declined to $65041.0 in Q4 2021, from $325964.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q3 2020 to a low of -$2.7 million in Q4 2019.
  • A 5-year average of $274253.1 and a median of $325964.0 in 2021 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2017 — Amortizatization of Intangibles soared 1307.82% — and 2019, when it sank 759.44%.
  • Tracing BRTX's Amortizatization of Intangibles over 5 years: stood at $485835.0 in 2017, then retreated by 16.54% to $405475.0 in 2018, then plunged by 759.44% to -$2.7 million in 2019, then surged by 42.67% to -$1.5 million in 2020, then soared by 104.24% to $65041.0 in 2021.
  • The last three Amortizatization of Intangibles figures came in at $65041.0 (Q4 2021), $325964.0 (Q3 2021), and $325374.0 (Q2 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 678,000.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 BioRestorative Therapies 1.94 Mn -1.02 Mn 17,964.00 -

Historic Data

Download Data
DateValue
Dec 31, 2021 65,041.00
Dec 31, 2021 65,041.00
Sep 30, 2021 325,964.00
Sep 30, 2021 325,964.00
Jun 30, 2021 325,374.00
Jun 30, 2021 325,374.00
Mar 31, 2021 417,160.00
Mar 31, 2021 417,160.00
Dec 31, 2020 -1.53 Mn
Dec 31, 2020 -1.53 Mn
Sep 30, 2020 1.74 Mn
Sep 30, 2020 1.74 Mn
Mar 31, 2020 1.07 Mn
Mar 31, 2020 1.07 Mn
Dec 31, 2019 -2.67 Mn
Dec 31, 2019 -2.67 Mn
Sep 30, 2019 1.49 Mn
Sep 30, 2019 1.49 Mn
Jun 30, 2019 991,261.00
Jun 30, 2019 991,261.00